See All Slides - tctmd.com

Slides

Presentation TCT 2017

The Potential for Neuromodulation in Heart Failure

Presenter: Felix Mahfoud

November 01, 2017

Presentation TCT 2017

24-month Results From a First-In-Human Data on the Paclitaxel Drug Coated Chocolate Coronary PTCA Balloon Catheters in De-Novo Coronary Lesions

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Georgios Bouras

November 01, 2017

Presentation TCT 2017

TAVR for Low-gradient AS (Normal and Reduced LVEF) Diagnosis and Management

Presenter: Gregory P. Fontana, Julinda Mehilli

November 01, 2017

Presentation TCT 2017

Devices for Cardio-Renal Failure: The Future of Heart Failure and Shock Therapies?

Presenter: Navin K. Kapur

November 01, 2017

Presentation TCT 2017

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 2-Year Clinical Follow-Up

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Pieter R. Stella

November 01, 2017

Presentation TCT 2017

TAVR for Severe AS With a Small Aortic Annulus

Presenter: Gregory P. Fontana, Josep Rodés-Cabau

November 01, 2017

Presentation TCT 2017

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Presenter: James E. Udelson

November 01, 2017

Presentation TCT 2017

Radial Hemostasis Is Facilitated With a Potassium Ferrate Hemostatic Patch(Statseal): Preliminary Results From the Randomized Controlled Statseal With TR Band Assessment Trial (STAT)

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Arnold Seto

November 01, 2017

Presentation TCT 2017

TAVR for Severe AS and Hypertrophic Cardiomyopathy

Presenter: Gregory P. Fontana, Amar Krishnaswamy

November 01, 2017

Presentation TCT 2017

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Presenter: Angeles Alonso Garcia

November 01, 2017

Advertisement

Slides

The Potential for Neuromodulation in Heart Failure

24-month Results From a First-In-Human Data on the Paclitaxel Drug Coated Chocolate Coronary PTCA Balloon Catheters in De-Novo Coronary Lesions

TAVR for Low-gradient AS (Normal and Reduced LVEF) Diagnosis and Management

Devices for Cardio-Renal Failure: The Future of Heart Failure and Shock Therapies?

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 2-Year Clinical Follow-Up

TAVR for Severe AS With a Small Aortic Annulus

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Radial Hemostasis Is Facilitated With a Potassium Ferrate Hemostatic Patch(Statseal): Preliminary Results From the Randomized Controlled Statseal With TR Band Assessment Trial (STAT)

TAVR for Severe AS and Hypertrophic Cardiomyopathy

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content